Back

Diagnostic and prognostic significance of serum levels of selenoprotein P in patients with pulmonary arterial hypertension

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension Diagnostic Methods ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Nobuhiro Kikuchi

Tohoku University, Sendai (Japan)

11 More presentations in this session

Presentation thumbnail
Doctor A. Vijiiac (Bucharest, RO)
Abstract
Presentation thumbnail
Ms L. Rodriguez (Barcelona, ES)
Abstract
Presentation thumbnail
Associate Professor R. Kockova (Hradec Kralove, CZ)
Abstract Slides
Presentation thumbnail
Doctor K. El Chilali (Recklinghausen, DE)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients
1 July 2021
thumbnail
Congress Presentation
Low levels of selenoprotein P associate with cognitive impairment in patients with acute heart failure
20 May 2023
thumbnail
Congress Presentation
Sex-dependent protective effect of combined application of solubilized ubiquinol and selenium on the development of monocrotaline (mct)-induced pulmonary hypertension in wistar rats
29 June 2021
thumbnail
Congress Presentation
Hepatokine selenoprotein P has an important role in cardiac remodeling.
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources